Effective Reduction of Gastric Cancer Risk With Regular Use of Nonsteroidal Anti-Inflammatory Drugs in Helicobacter Pylori–Infected Patients

J Clin Oncol. 2010 May 17;[Epub Ahead of Print], CY Wu, MS Wu, KN Kuo, CB Wang, YJ Chen, JT Lin

TAKE-HOME MESSAGE

Abstract

SUMMARY

OncologySTAT Editorial Team

Chronic inflammation, such as that associated with Helicobacter pylori (H pylori) infection, plays a role in gastric carcinogenesis. Meta-analyses have shown that use of aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with a reduced risk of gastric cancer. Wu et al conducted a retrospective cohort study to determine the interaction between NSAID use and H pylori infection. In particular, the objective of the analysis was to determine the subpopulation for whom the benefits...

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

About Our Journal Scans

View a list of journals that the OncologySTAT editorial team scans every week in order to bring you the most practice-relevant original research and review articles.

Sign up for our newsletters

Too busy to follow cancer's top stories? Sign-up for 1 or more of our free newsletters -- delivered weekly to your inbox.

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration